The Journal of Clinical Investigation's Conversations with Giants in Medicine: Katalin Karikó
Ushma S. Neill Nov 1, 2021

It is the scientific body of work of biochemist Katalin Karikó, Senior Vice President at BioNTech SE, that made these vaccines possible. Karikó’s work into nucleoside modifications to suppress immunogenicity of RNA provided the key to successful vaccines and an exit from the global COVID pandemic. In this episode, Ushma Neill discusses this and much more with Dr. Karikó.

https://www.jci.org/articles/view/155559
https://www.jci.org/articles/view/155559/pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553550/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553550/pdf/jci-131-155559.pdf
J Clin Invest. 2021;131(21):e155559. https://doi.org/10.1172/JCI155559.